Stealth Drought Hits Sierras and California–April 12 heavy rains and snow eases drought risk
April 12 A Very Wet Spring Eases Drought Risk (data coming with 2.66 inches in April) Stealth Drought Hits Sierra Nevada in 2020 Dry Spell Yet Ahead But Previous Wet Years Have Allayed Concerns. I just heard from my son that Bridger Bowl near Bozeman, Montana had 6 ft of snow since FEB 1 and...
Raygent Focus Stocks -2020: Bristol-Myers, (BMY), Glaukos (GKOS),Teledoc (TDOC)…Update-2
Update-2 Mid-day trading 2/21 NAZ down 1.14%-Biotech stocks held their levels on a down day. Most large cap Raygent focus stocks are in green: ABBV,BMY,GILD up 4%, RHHBY. Mid-caps are mixed but BMRN is up 5%. Healthcare sector was a leader up 0.1% ============ Update-1 Feb 19 A Risk -On Day...
Large Cap Biopharmaceutical Companies-Metrics and Valuations…BMY VRTX
Large Cap Biopharmaceutical Companies - Q1 2020 Update The IBB is at $122.69 near the 52 week high but short of 5 year high of $132.53 from Jy '15. FWD PEs of sector are still lower than the market with S&P-500 at 18.9x. Good growth expected. Our Top Picks have done well especially after...
Biotech Reversal Off 2020 Bottom But Within Trading Range: Update-2.. Abbvie (ABBV)
Update-2 2/10...Rally has expanded to mid-caps:ALNY ACAD GWPH ICPT SRPT Etc. ======= Update-1 2/7. 2p ...Abbvie (ABBV) Another one of our top large cap picks ABBV is up 6% o the $92 handle as of mid-day trading on earnings and Allergan acquisition. Full year EPS was $5.28 on GAAP basis on...
Bearish Pattern Emerging for Biotech-Geopolitical News Overwhelms Market…Update-1
Update-1 2/3...3:30p EST... Biopharma stocks firm up after a bad week Large caps are strong with Gilead Sciences (GILD) up over 5% on a story about an experimental antiviral therapy for coronavirus China. GILD is one of the leading antiviral companies for HIV and HCV. Mid-caps in green screen...